We are live on ! Find out more
WP

Waycross Partners Portfolio holdings

AUM $1.05B
1-Year Est. Return 20.92%
This Fund
S&P 500
This Quarter Est. Return
+3.6%
1 Year Est. Return
+20.92%
3 Year Est. Return
+78.91%
5 Year Est. Return
+114.23%
10 Year Est. Return
AUM
$652M
AUM Growth
+$70.4M
Cap. Flow
+$56M
Cap. Flow %
8.59%
Top 10 Hldgs %
48.55%
Holding
77
New
8
Increased
28
Reduced
3
Closed
6

Top Buys

Rank Stock Value
1
HON icon
Honeywell
HON
+$14.2M
2
DLTR icon
Dollar Tree
DLTR
+$13.8M
3
LOW icon
Lowe's Companies
LOW
+$13.4M
4
UNH icon
UnitedHealth
UNH
+$9.65M
5
MSFT icon
Microsoft
MSFT
+$4.2M

Top Sells

Rank Stock Value
1
TJX icon
TJX Companies
TJX
+$13.6M
2
ULTA icon
Ulta Beauty
ULTA
+$13.1M
3
CB icon
Chubb
CB
+$12.7M
4
HUM icon
Humana
HUM
+$8.82M
5
ADBE icon
Adobe
ADBE
+$2.02M

Sector Composition

Rank Sector Weight
1 Technology 26.66%
2 Healthcare 18.55%
3 Financials 13.45%
4 Consumer Discretionary 11.14%
5 Communication Services 10.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MSFT icon
1
Microsoft
MSFT
$2.98T
$47.8M 7.34%
107,037
+9,934
+10% +$4.2M
NVDA icon
2
NVIDIA
NVDA
$5.02T
$47.4M 7.27%
383,725
-6,035
-2% -$610K
AAPL icon
3
Apple
AAPL
$4.89T
$39.6M 6.08%
188,246
+18,460
+11% +$3.44M
GOOGL icon
4
Alphabet (Google) Class A
GOOGL
$4.33T
$34M 5.22%
186,756
+18,302
+11% +$3.09M
META icon
5
Meta Platforms (Facebook)
META
$1.69T
$32.3M 4.96%
64,066
+5,012
+8% +$2.44M
AMZN icon
6
Amazon
AMZN
$2.69T
$29.7M 4.56%
153,648
+18,506
+14% +$3.4M
ISRG icon
7
Intuitive Surgical
ISRG
$142B
$23.4M 3.6%
52,710
+5,313
+11% +$2.12M
ABBV icon
8
AbbVie
ABBV
$449B
$22M 3.38%
128,267
+12,086
+10% +$2M
GS icon
9
Goldman Sachs
GS
$323B
$20.4M 3.12%
44,993
+4,331
+11% +$1.9M
ADI icon
10
Analog Devices
ADI
$185B
$19.8M 3.03%
86,570
+9,136
+12% +$1.95M
TGT icon
11
Target
TGT
$63.7B
$18.1M 2.78%
122,435
+11,945
+11% +$1.88M
MA icon
12
Mastercard
MA
$487B
$17.2M 2.64%
39,019
+4,243
+12% +$1.93M
WFC icon
13
Wells Fargo
WFC
$267B
$16.8M 2.57%
282,039
+31,033
+12% +$1.83M
EMR icon
14
Emerson Electric
EMR
$77.9B
$16.6M 2.55%
151,083
+17,567
+13% +$1.94M
EW icon
15
Edwards Lifesciences
EW
$50.6B
$15.4M 2.36%
166,766
+32,296
+24% +$2.86M
SYY icon
16
Sysco
SYY
$39.3B
$15.1M 2.32%
211,643
+23,126
+12% +$1.73M
HON icon
17
Honeywell
HON
$71.7B
$15M 2.3%
+74,382
New +$14.2M
TMO icon
18
Thermo Fisher Scientific
TMO
$202B
$13.8M 2.12%
25,014
+2,791
+13% +$1.6M
SBUX icon
19
Starbucks
SBUX
$124B
$13.7M 2.11%
176,614
+18,264
+12% +$1.49M
MRVL icon
20
Marvell Technology
MRVL
$169B
$13.3M 2.05%
190,868
+22,156
+13% +$1.55M
LOW icon
21
Lowe's Companies
LOW
$121B
$13M 1.99%
+58,742
New +$13.4M
V icon
22
Visa
V
$694B
$12.7M 1.94%
48,208
+4,555
+10% +$1.25M
DLTR icon
23
Dollar Tree
DLTR
$24.7B
$12.4M 1.91%
+116,544
New +$13.8M
CVS icon
24
CVS Health
CVS
$136B
$12.3M 1.88%
207,539
+21,135
+11% +$1.32M
UNH icon
25
UnitedHealth
UNH
$384B
$12.1M 1.85%
23,687
+19,687
+492% +$9.65M

Similar funds

Waycross Partners's Q2 2024 Portfolio in Review

As of Q2 2024, Waycross Partners held 77 positions worth $652M, up 12% from $581M the previous quarter. Its ten largest holdings account for 49% of the portfolio.

Waycross Partners deployed $56M of net new capital in Q2 2024, opening 8 new positions and adding to 28 existing holdings. Its largest new stake was Honeywell: 74,382 shares worth $15M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 24% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was TJX Companies, an estimated $13.6M trimmed.

  • Waycross Partners's largest Q2 2024 buy was Honeywell: 74,382 shares worth $15M.
  • Waycross Partners added most to UnitedHealth in Q2 2024, an estimated $9.65M increase.
  • Waycross Partners's biggest Q2 2024 reduction was TJX Companies, cutting an estimated $13.6M.
  • Waycross Partners fully exited Ulta Beauty in Q2 2024, selling an estimated $13.1M.
  • Waycross Partners's ten largest holdings make up 49% of its $652M portfolio in Q2 2024.
  • Waycross Partners opened 8 new positions and closed 6 in Q2 2024.
  • Waycross Partners's portfolio value rose 12% quarter-over-quarter to $652M.

Based on Waycross Partners's 13F filing for Q2 2024, filed 9 Aug 2024.